Galecto Inc (GLTO)
0.491
-0.03
(-6.46%)
USD |
NASDAQ |
Jun 25, 16:00
0.491
0.00 (0.00%)
After-Hours: 20:00
Galecto Total Assets (Quarterly): 32.48M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 32.48M |
| December 31, 2023 | 38.23M |
| September 30, 2023 | 50.05M |
| June 30, 2023 | 58.80M |
| March 31, 2023 | 64.63M |
| December 31, 2022 | 73.19M |
| September 30, 2022 | 82.02M |
| June 30, 2022 | 92.86M |
| March 31, 2022 | 108.93M |
| Date | Value |
|---|---|
| December 31, 2021 | 122.22M |
| September 30, 2021 | 135.87M |
| June 30, 2021 | 146.82M |
| March 31, 2021 | 158.66M |
| December 31, 2020 | 171.60M |
| September 30, 2020 | 98.15M |
| June 30, 2020 | 40.96M |
| December 31, 2019 | 56.61M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
32.48M
Minimum
Mar 2024
171.60M
Maximum
Dec 2020
90.12M
Average
82.02M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| Novo Nordisk A/S | 43.24B |
| Genmab A/S | 5.306B |
| Ascendis Pharma A/S | 866.62M |
| Evaxion Biotech AS | 22.65M |
| IO Biotech Inc | 128.16M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.318M |
| Shareholders Equity (Quarterly) | 28.16M |